ECSP20017939A - Composiciones farmacéuticas - Google Patents

Composiciones farmacéuticas

Info

Publication number
ECSP20017939A
ECSP20017939A ECSENADI202017939A ECDI202017939A ECSP20017939A EC SP20017939 A ECSP20017939 A EC SP20017939A EC SENADI202017939 A ECSENADI202017939 A EC SENADI202017939A EC DI202017939 A ECDI202017939 A EC DI202017939A EC SP20017939 A ECSP20017939 A EC SP20017939A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
attached
Prior art date
Application number
ECSENADI202017939A
Other languages
English (en)
Inventor
Stephen John Pethen
Christopher Martyn Yea
Michael Bryan Roe
Gary Cook
Sally Marsh
Original Assignee
Kalvista Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1713660.7A external-priority patent/GB201713660D0/en
Application filed by Kalvista Pharmaceuticals Ltd filed Critical Kalvista Pharmaceuticals Ltd
Publication of ECSP20017939A publication Critical patent/ECSP20017939A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se adjunta resumen
ECSENADI202017939A 2017-08-11 2020-03-11 Composiciones farmacéuticas ECSP20017939A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762544346P 2017-08-11 2017-08-11
GBGB1713660.7A GB201713660D0 (en) 2017-08-25 2017-08-25 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ECSP20017939A true ECSP20017939A (es) 2020-04-22

Family

ID=70976595

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202017939A ECSP20017939A (es) 2017-08-11 2020-03-11 Composiciones farmacéuticas

Country Status (8)

Country Link
CL (1) CL2020000356A1 (es)
CO (1) CO2020002287A2 (es)
EC (1) ECSP20017939A (es)
IL (1) IL272428A (es)
MX (1) MX2020001356A (es)
PH (1) PH12020500246A1 (es)
RU (1) RU2020109955A (es)
UA (1) UA125537C2 (es)

Also Published As

Publication number Publication date
RU2020109955A (ru) 2021-09-14
IL272428A (en) 2020-03-31
CL2020000356A1 (es) 2020-06-19
UA125537C2 (uk) 2022-04-13
CO2020002287A2 (es) 2020-06-09
MX2020001356A (es) 2020-03-20
RU2020109955A3 (es) 2022-01-24
PH12020500246A1 (en) 2021-03-15

Similar Documents

Publication Publication Date Title
ECSP17029371A (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
CL2019000992A1 (es) Conjugados de pirrolobenzodiazepina.
CO2017002532A2 (es) Indazoles sustituidos con bencilo como inhibidores de bub1
PL3510033T3 (pl) Związki i kompozycje jako inhibitory endosomalnych receptorów toll- podobnych
PL4393545T3 (pl) Nowe zastosowania pochodnych piperydynylo-indolowych
EP3606559C0 (en) BIOORTHOGONAL COMPOSITIONS
EP3509581A4 (en) FORMULATIONS OF (R
TWD174683S (zh) 戒指
UY36498A (es) Picolinamidas como fungicidas
ECSP17015977A (es) Terapia de combinacion
PT3645518T (pt) Síntese de omecamtiv mecarbil
EP3364944C0 (en) PHARMACEUTICAL COMPOSITIONS OF IL-2
EP3688069A4 (en) SILICONE COMPOSITIONS
EP3860585A4 (en) Therapeutic compositions
MX2018007390A (es) Composiciones que comprenden acido 15-hidroxi eicosapentaenoico (15-hepe) y metodos de uso del mismo.
LT3651736T (lt) Ilgai veikiančios kompozicijos
EP3674359A4 (en) LATEX COMPOSITION
ECSP18018793A (es) Compuestos útiles para inhibir ror-gamma-t
DK4234656T3 (da) Sammensætninger
MX2017000862A (es) Formulacion de factor viii.
DK3678644T3 (da) Formuleringer af copanlisib
EP3894418A4 (en) PRODUCTION OF TRIIODOSILANES
IL285765A (en) Therapeutic uses of dulaglutide
PT3765379T (pt) Composições
MX373197B (es) Formulaciones estables de undecanoato de testosterona.